Corey J. Langer, MD, discusses the need for reflex testing in patients with non–small cell lung cancer.
Advances in Risk-Stratification and Therapeutic Options for Early-Stage Non–Small Cell Lung Cancer
John F. Lazar, MD, discusses risk stratification for chemotherapy and adjuvant therapy in lung cancer.
Rodolfo Bordoni, MD, discusses the utility of adjuvant osimertinib in lung cancer.
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
Hematologists Highlight Top Data From ASCO 2026
3
Aglatimagene Besadenovec Plus EBRT Improves Prostate Cancer-Specific DFS
4
INDEPENDENCE, Type II JAK Inhibitor Data Highlight Key MPN and AML Data Arriving at EHA 2026
5